Condition 101 About Leiomyosarcoma

What is the definition of Leiomyosarcoma?

A leiomyosarcoma is a rare cancerous tumor of the smooth muscle cells. It is most often found in the uterus or abdomen.

REFERENCES

Goldblum JR, Folpe AL, Weiss SW. Leiomyosarcoma. In: Goldblum JR, Folpe AL, Weiss SW, eds. Enzinger and Weiss's Soft Tissue Tumors. 7th ed. Philadelphia, PA: Elsevier; 2020:chap 16.

National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology (NCCN guidelines): soft tissue sarcoma. Version 1.2018. www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Updated October 31, 2017. Accessed July 15, 2020.

Top Global Doctors For Leiomyosarcoma

View All Doctors

Latest Advances On Leiomyosarcoma

  • Condition: Primary Leiomyosarcoma of Breast
  • Journal: BMJ case reports
  • Treatment Used: Wide Local Excision and Planned Cosmetic Breast Reduction Surgery
  • Number of Patients: 1
  • Published —
This case report describes a 61-year-old woman diagnosed with rare primary leiomyosarcoma of the breast treated with wide local excision and planned cosmetic breast reduction surgery.
  • Condition: Leiomyosarcoma of the Extremities
  • Journal: Anticancer research
  • Treatment Used: Surgery
  • Number of Patients: 75
  • Published —
The study researched the use of surgery in patients with leiomyosarcoma of the extremities.
View All Latest Advances

Clinical Trials For Leiomyosarcoma

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: May 1, 2021
A Randomized Phase II Trial Comparing the Activity of trabectedIn vs Gemcitabine in Patients With Metastatic or Locally Advanced Leiomyosarcoma Pretreated With Conventional Chemotherapy
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Behavioral, Procedure
  • Participants: 25
  • Start Date: January 28, 2021
Phase 2 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Gemcitabine Followed by Systemic Adjuvant Chemotherapy With Dacarbazine for Locally Recurrent Uterine Leiomyosarcoma (LMS)
View All Clinical Trials